Zwj Investment Counsel Inc Gilead Sciences, Inc. Transaction History

Zwj Investment Counsel Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $361,562 - $463,110	-5,773 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $355,732 - $391,293	5,773 New	5,773 $375,000
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $246,726 - $272,343	-3,947 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $27,841 - $31,220	-450 Reduced 10.23%	3,947 $267,000
Q1 2019 May 21, 2019	SELL	$62.53 - $70.05 $98,984 - $110,889	-1,583 Reduced 26.47%	4,397 $286,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $13,803 - $18,012	-228 Reduced 3.67%	5,980 $374,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $2,494 - $2,762	35 Added 0.57%	6,208 $479,000
Q2 2018 Jul 20, 2018	SELL	$64.88 - $75.68 $14.4 Million - $16.8 Million	-222,292 Reduced 97.3%	6,173 $437,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $1.26 Million - $1.53 Million	-17,266 Reduced 7.03%	228,465 $17.2 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $1.23 Million - $1.44 Million	-17,264 Reduced 6.56%	245,731 $17.6 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $19 Million - $22.5 Million	262,995	262,995 $21.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Zwj Investment Counsel Inc with notifications on news.